Critical Care & Pulmonary Medicine: An Update and Review

Venue: Hyatt Sarasota on Sarasota Bay

Location: Sarasota, Florida, United States

Event Date/Time: Feb 09, 2009 End Date/Time: Feb 13, 2009
Registration Date: Feb 09, 2009
Report as Spam


SPECIFIC OBJECTIVES FOR THIS COURSE: DAY 1 - COPD – OVERVIEW OF PATIENT MANAGEMENT - Definition and pathophysiology of COPD. Natural history and clinical features. Adverse health effects of cigarette smoking and recommendations for helping patients “kick the habit”. Aspects of outpatient management, long term oxygen therapy, pharmacologic treatment. Surgical treatment options for emphysema. “Nuts and Bolts” of Pulmonary Function Testing – Components of PFTs: spirometry, lung volumes, diffusion. Indications for PFTs. When bronchodilator and bronchoprovocation studies are useful. Approach to PFT interpretation and common patterns. Different patterns of upper airway obstruction. PFTs will be presented for interpretation and review. ASTHMA UPDATE - Pathophysiology. Typical and atypical clinical presentations with cases serving as examples. Diagnostic modalities. Approach to treatment: bronchodilators, corticosteroids and methylxanthines. Techniques to ensure patient compliance. Proper inhaler technique, peak flow monitoring. Patient who is not responding and indications for subspecialty referral. DAY 2 - DISORDERS OF SLEEP – OBSTRUCTIVE SLEEP APNEA AND OTHERS - Epidemiology of obstructive sleep apnea. Clinical presentation and how to take a thorough “sleep history.” Diagnostic work-up including overnight polysomnography. Treatment modalities: CPAP, dental appliances, surgery, others. Obesity hypoventilation syndrome, central sleep apnea, Cheyne Stokes breathing, narcolepsy, periodic leg movements of sleep. PLEURAL DISEASES - Anatomy of the pleural space and the physiology of pleural fluid formation. Imaging modalities available: plain chest radiography, ultrasonography, CT scanning. Indications and contraindications for thoracentesis. Characterize pleural fluid in a cost effective manner with an emphasis on differential diagnosis. Indications for pleural biopsy and diagnostic pleuroscopy. Treatment modalities. Cases demonstrating some common and some not so common causes of pleural effusion. PATIENT WITH CHRONIC COUGH - Pathophysiology and most common etiologies of cough. Features of a focused history and physical. Approach to diagnosis and treatment. PREOPERATIVE PULMONARY ASSESSMENT – Respiratory effects of anesthesia and surgery with emphasis on patients with at-risk complications. Perioperative risk factors associated with post-op pulmonary complications. Elements of appropriate preoperative evaluation: the role of arterial blood gas measurement, spirometry. Preoperative measures that can minimize operative and postoperative respiratory complications. DAY 3 - ACID-BASE DISTURBANCES - Primary metabolic and respiratory acid- base disturbances and their compensatory mechanisms. Approach to the interpretation of any acid-base problem. Differential diagnosis of the major simple and mixed acid-base disturbances. Illustrative case studies will be discussed. ACUTE RESPIRATORY FAILURE AND MECHANICAL VENTILATION - Pathophysiology and differential diagnosis of acute hypoxemic and hypersonic respiratory failure. Pathophysiology and differential diagnosis of acute respiratory failure. Concepts of management for patients on mechanical ventilation. Commonly used ventilator modes. Use of positive end expiratory pressure (PEEP). Indications for and complications of mechanical ventilation. Weaning, general principles and strategies for weaning from mechanical ventilation. SHOCK AND HEMODYNAMIC MONITORING - Define shock and describe the causes. Pathophysiology of common entities. Basic resuscitation techniques: volume replacement, use of vasopressors. Controversies surrounding the use of invasive hemodynamic monitoring. New treatments for septic shock. Use of activated protein C and the role of corticosteroids. COMMUNITY ACQUIRED PNEUMONIA - Categorize patients with respect to severity of illness. Strategy to triage patients - outpatient therapy, hospitalize or ICU. Pathogens that commonly cause community acquired pneumonia. Current status of diagnostic work-up including the use of cultures, gram stains, serology, bronchoscopy. DAY 4 - TUBERCULOSIS - Epidemiology of tuberculosis. Clinical presentations: pulmonary, pleural, extrapulmonary tuberculosis. ATS/CDC criteria for positive tuberculin skin test. Treatment of LTBI. Role of skin testing, sputum examination, bronchoscopy in diagnosis. Recent ATS/CDC/IDSA Guidelines for TB therapy. Multi-drug resistant tuberculosis and implications for therapy. LUNG CANCER - Epidemiology of lung cancer. Major types of lung carcinoma, particularly small cell and non-small cell cancer. Basic clinical aspects of both small cell and non-small cell cancer including staging, natural history, associated extrapulmonary syndromes. Diagnostic strategy for patients with suspected lung cancer. Treatment options for small cell and non-small cell lung cancer. CRITICAL CARE CASES FOR REVIEW - Critical Care cases will be presented with audience participation. X-rays and other diagnostic studies will be shown in an attempt to emphasize some of the common problems seen in the ICU. Cases will include a variety of pulmonary as well as non-pulmonary topics. Patient with occupational asthma. Differential diagnosis and approach to a patient with a nonresolving infiltrate. Causes and evaluation of a solitary pulmonary nodule. DAY 5 - INTERSTITIAL LUNG DISEASE – THE BASICS - Spectrum of interstitial lung disease. Diagnostic work-up, which can include high resolution CT scanning and tissue biopsy. Clinical and radiographic manifestations of sarcoidosis. Typical presentation of idiopathic pulmonary fibrosis as well as management issues. Cases with x-rays, CT scans, pathology to illustrate important features. PULMONARY CASES FOR REVIEW - Cases will be discussed in order to review some of the important points outlined during the week. Session will be interactive. HEMOPTYSIS - Causes for hemoptysis. Severity of a bleeding episode. Diagnostic modalities available. Basic therapy and indications for specialist referral. PULMONARY THROMBOEMBOLIC DISEASE - Epidemiology, risk factors, & clinical presentation of PE & DVT. Role of DVT prophylaxis and the status of low molecular weight heparin. Diagnostic work-up: V/Q scanning, lower extremity studies, CT scanning, pulmonary angiography, others. Treatment modalities: anticoagulation, thrombolysis, vena cava filters.


1000 Boulevard of the Arts
United States

Additional Information

Physician Fees $745.00 Regular Registration (30 days prior to seminar start date) $795.00 Late Registration Non Physician/Resident* Fees $645.00 Regular Registration (30 days prior to seminar start date) $695.00 Late Registration